Brief: Lumos Pharma Announces OraGrowtH212 Trial Of LUM-201 In PGHD Is Open For Enrollment
28/06/2021 14:03
June 28 (Reuters) - Lumos Pharma Inc LUMO.O :
* LUMOS PHARMA ANNOUNCES ORAGROWTH212 TRIAL OF LUM-201 IN
PGHD IS
OPEN FOR ENROLLMENT
Source text for Eikon: ID:nGNX3Cs5DZ
Further company coverage: LUMO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lumos Pharma
See all newsLumos Pharma Inc expected to post a loss of 76 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Apple, Hershey, Dow
U.S. STOCKS ON THE MOVE-Magnite, Nvidia, Tesla
Lumos Pharma climbs on $38 mln go-private deal
Brief: Lumos Pharma Enters Into Definitive Merger Agreement With Double Point Ventures To Go Private Via A Tender Offer Of $4.25 Cash Per Share Plus Contingent Value Rights (Cvr)